about
Immunization of mice with single PspA fragments induces antibodies capable of mediating complement deposition on different pneumococcal strains and cross-protection.Characterization of protective immune responses induced by pneumococcal surface protein A in fusion with pneumolysin derivatives.Fusion proteins containing family 1 and family 2 PspA fragments elicit protection against Streptococcus pneumoniae that correlates with antibody-mediated enhancement of complement deposition.Optimized immune response elicited by a DNA vaccine expressing pneumococcal surface protein a is characterized by a balanced immunoglobulin G1 (IgG1)/IgG2a ratio and proinflammatory cytokine productionRole of Streptococcus pneumoniae Proteins in Evasion of Complement-Mediated Immunity.A protein chimera including PspA in fusion with PotD is protective against invasive pneumococcal infection and reduces nasopharyngeal colonization in mice.IL-17A and complement contribute to killing of pneumococci following immunization with a pneumococcal whole cell vaccine.Combined effects of lactoferrin and lysozyme on Streptococcus pneumoniae killing.Systemic immunization with rPotD reduces Streptococcus pneumoniae nasopharyngeal colonization in mice.Rational selection of broadly cross-reactive family 2 PspA molecules for inclusion in chimeric pneumococcal vaccines.Selection and validation of reference genes for gene expression studies in Klebsiella pneumoniae using Reverse Transcription Quantitative real-time PCR.Protection induced by pneumococcal surface protein A (PspA) is enhanced by conjugation to a Streptococcus pneumoniae capsular polysaccharideRecognition of pneumococcal isolates by antisera raised against PspA fragments from different cladesNasal immunization of mice with Lactobacillus casei expressing the Pneumococcal Surface Protein A: induction of antibodies, complement deposition and partial protection against Streptococcus pneumoniae challengeDNA vaccines expressing pneumococcal surface protein A (PspA) elicit protection levels comparable to recombinant proteinContribution of Streptococcus Mutans Virulence Factors and Saliva Agglutinating Capacity to Caries Susceptibility in Children: A Preliminary StudyChildhood Obesity and Firmicutes/Bacteroidetes Ratio in the Gut Microbiota: A Systematic Review
P50
Q33725192-C42BB00A-6B7D-43C4-A603-36012970827EQ34637890-B6B3115C-76A6-4417-95E2-9BD20A2DFBCEQ36314000-ACB9F749-8C98-45CA-8858-216675F0F3F2Q36497698-40E3F7EE-2BBE-42F9-B08C-4C64D607CAC4Q39164566-C945377D-2650-45BE-9A9A-CABB2ACE2B93Q40089381-B049B605-B7A6-4D32-B7E9-B395096EC5CFQ40345279-A9ACC8E6-2600-44A8-B8C6-A73E4E202371Q41461047-6A9E07BD-4D92-4C37-84D5-FB1F5F860778Q47981250-D957FE55-46AB-42F2-80F0-C8F1C07AC93FQ50950068-74B4770B-78BF-41F9-842C-45740B043314Q55196635-24D4AE63-FF15-41F0-84C2-48CB7DCAE66FQ58768117-E129A667-EBA6-429B-B97A-CCC3B62EADE3Q80738099-5FE13630-0BAF-4934-8BE2-30AA27E49AE0Q81057301-91E49301-1ACE-44A6-80E8-6FFCDE772531Q82809417-3CC64836-B497-40C3-9C05-9335707CD1A6Q88482318-C93D2AE5-DAF3-4442-BFB0-5DA761421408Q91295455-D5163F4A-5ADE-4ACC-8E2C-1B57F3324B96
P50
description
researcher ORCID ID = 0000-0002-7829-3435
@en
wetenschapper
@nl
name
Michelle Darrieux
@ast
Michelle Darrieux
@en
Michelle Darrieux
@es
Michelle Darrieux
@nl
type
label
Michelle Darrieux
@ast
Michelle Darrieux
@en
Michelle Darrieux
@es
Michelle Darrieux
@nl
prefLabel
Michelle Darrieux
@ast
Michelle Darrieux
@en
Michelle Darrieux
@es
Michelle Darrieux
@nl
P106
P21
P31
P496
0000-0002-7829-3435